tm logo

Monitor this mark

View On USPTO

ALIZARIN
Live/Pending
PUBLISHED FOR OPPOSITION

on 08 Oct 2024

Last Applicant/ Owned by

Boehringer Ingelheim International GmbH

Binger Strasse 17355218 Ingelheim

DE

Serial Number

79395271 filed on 29th Jan 2024

Registration Number

N/A

Correspondent Address

Max Moskowitz

Max Moskowitz OSTROLENK FABER LLP

New York, NY 10022

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

ALIZARIN

Scientific research in the field of prevention and treatment of diabetic related diseases; providing medical and scientific research information in the field of diabetic related diseases.

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Scientific research in the field of prevention and treatment of diabetic related diseases; providing medical and scientific research information in the field of diabetic related diseases.

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79395271

Mark Type

No Service Mark

Attorney Docket Number

No TE/3974-1044

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
08th Oct 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08th Oct 2024PUBLISHED FOR OPPOSITION
18th Sep 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03rd Sep 2024APPROVED FOR PUB - PRINCIPAL REGISTER
01st Sep 2024REFUSAL PROCESSED BY IB
27th Aug 2024TEAS/EMAIL CORRESPONDENCE ENTERED
26th Aug 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
26th Aug 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
15th Aug 2024REFUSAL PROCESSED BY MPU
15th Aug 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB